SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-015654
Filing Date
2017-08-04
Accepted
2017-08-04 16:03:25
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20170630.htm 10-Q 1861830
2 EX-31.1 pti-ex311_6.htm EX-31.1 11671
3 EX-31.2 pti-ex312_7.htm EX-31.2 11624
4 EX-32.1 pti-ex321_8.htm EX-32.1 13234
  Complete submission text file 0001564590-17-015654.txt   5091209

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pti-20170630.xml EX-101.INS 1032713
6 XBRL TAXONOMY EXTENSION SCHEMA pti-20170630.xsd EX-101.SCH 30650
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20170630_cal.xml EX-101.CAL 43842
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20170630_def.xml EX-101.DEF 49818
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20170630_lab.xml EX-101.LAB 223368
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20170630_pre.xml EX-101.PRE 163542
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 171008644
SIC: 2834 Pharmaceutical Preparations